10,882 results found

Foley & Lardner LLP Partner Kyle Faget explains the underlying intent and purpose of the federal Anti-Kickback Statute in a four-part video series LexisNexis Practical Guidance

For the first time since the enactment of the MDRP, the Centers for Medicare and Medicaid Services (CMS) revised the NDRA entered into between drug manufacturers and the U.S. Department of HHS.

Beginning in July, 2019, the Centers for Medicare & Medicaid Services (CMS) will direct Medicare Part A/B Macs to perform claim validation edits and return all claims to hospital providers if the address included...

Academic Medical Centers and teaching hospitals (AMC/TH) are increasingly choosing to affiliate in some manner with other health care providers.

Momentum for "additive manufacturing" (aka "3D printing") continues to grow.

At a recent nanotech conference hosted by the NanoBusiness Commercialization Association, we received an update on nanotech patent trends from Jerry Lorengo, a Group Director with the US Patent Office.

Some of the most commercially successful products to arise out of nanotechnology in terms of sheer size of revenues generated are nanotech drug formulations.

The National Institutes of Health announced the enrollment of the first participants as beta testers of the "All of Us" research program.

The National Institutes of Health (NIH) recently announced the launch of a major artificial intelligence (AI) initiative aimed at improving the efficiency...

Late last week, President Obama announced that more than 8 million had people signed up for health insurance under the Affordable Care Act.

The September 3, 2012 issue of C&EN discusses what it calls an "onslaught of nanotech drugs coming down the pike" for FDA review.

Oracle announced that Larry Ellison (Oracle's Chairman and Chief Technology Officer) that "Working together, Cerner and Oracle have the capacity to transform healthcare delivery by providing medical professionals...

We are in the midst of a trend involving the "outsourcing" of certain outpatient and ambulatory services by hospitals and health systems.

Pharmaceutical and medical device manufacturers and GPOs are required to report payments or other transfers made to physicians and teaching hospitals.

The penalties in Massachusetts were originally set to start on January 1, 2022.

The American Telemedicine Association released draft Practice Guidelines for Real-time, Direct-to-Patient Primary Urgent Care Telemedicine.

The Department of Health and Human Services (HHS) published a proposed rule on November 28, 2025 (the Proposed Rule) that would carve out account-based group health plans...